6505--Imiquimod 5% Cream and Placebo Manufacturing

The Department of Veterans Affairs Veterans Health Administration, specifically Network Contracting Office 22, is seeking to procure Imiquimod 5% cream and matching placebo for a clinical research study through Request for Quote (RFQ) 36C26225Q0122. This solicitation is a combined synopsis/solicitation for commercial items prepared under Federal Acquisition Regulation streamlined procedures, with quotes being requested directly without a separate written solicitation document. The contract requires vendors to provide FDA-approved Imiquimod 5% cream with therapeutic equivalence to Aldara, along with a matching placebo in an oil-in-water cream base, packaged in specific unit dose configurations. Evaluation will be conducted using a lowest price, technically acceptable methodology, with vendors required to demonstrate authorization as dealers or distributors. The deadline for submitting quotes is December 9, 2024, at 7:00 AM PST, with all inquiries to be sent electronically to Anthony.DelaCruz@va.gov and reference the solicitation number.

The contract is an unrestricted, firm-fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with a three-year potential duration, including a base period and two option years. Quantity requirements range from a minimum of 30,000 to a maximum of 135,000 units in the base year, scaling to 30,000-165,000 units in option year one, and 0-75,000 units in option year two for both active and placebo products. The place of performance is located at 2401 Centre Ave SE in Albuquerque, New Mexico, specifically at the VA Cooperative Studies Program Clinical Research Pharmacy. The procurement falls under the North American Industry Classification System (NAICS) code 325412 for Pharmaceutical Preparation Manufacturing and Product Service Code 6505 for Drugs and Biologicals. No specific set-aside designations are noted, indicating the solicitation is open to all qualified vendors who can meet the technical and production requirements.